Share
 
Title
Code
Session Type
Track
CME accreditation
ROOM/CHANNEL
Date Time
Moderator

This session will review the local and international impact of the harm reduction movement to explore if decriminalization of drug use and possession can become the norm in a frequently changing environment of policy reforms, conflict, social crises and community involvement through local activism.

14:15
2 min
Welcome
Michel KAZATCHKINE, Global Commission on Drug Policy, Switzerland
14:17
3 min
Introductory remarks
Admiral Rachel LEVINE, US Public Health Service Commissioned Corps, United States
14:20
3 min
Introductory remarks
Minister Carolyn BENNETT
14:23
8 min
Public health and prisons: Making a case for decriminalization
Frederick ALTICE, Yale University School of Medicine, United States
Slides
14:31
8 min
Regional perspective from EECA
Alona MAZHNAIA, Johns Hopkins School of Public Health, Ukraine
PDF

14:39
8 min
Stigma and discrimination of people who use drugs
Shaun SHELLY, TB/HIV Care Association, South Africa
14:47
8 min
The opioid crisis in the United States: Implications for harm reduction, HIV and policies
Ethan NADELMANN, PSYCHOACTIVE podcast, United States
14:55
15 min
Panel discussion
Frederick ALTICE, Yale University School of Medicine, United States
Michel KAZATCHKINE, Global Commission on Drug Policy, Switzerland
Alona MAZHNAIA, Johns Hopkins School of Public Health, Ukraine
Shaun SHELLY, TB/HIV Care Association, South Africa
Ethan NADELMANN, PSYCHOACTIVE podcast, United States
15:10
5 min
Closing remarks: Next steps in drug policy reform
Helen CLARK, Global Commission on Drug Policy, New Zealand

AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT